Key Insights

Highlights

Success Rate

98% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.4%

1 terminated out of 72 trials

Success Rate

97.6%

+11.1% vs benchmark

Late-Stage Pipeline

18%

13 trials in Phase 3/4

Results Transparency

13%

5 of 40 completed with results

Key Signals

5 with results98% success

Data Visualizations

Phase Distribution

49Total
Not Applicable (25)
Early P 1 (1)
P 1 (6)
P 2 (4)
P 3 (5)
P 4 (8)

Trial Status

Completed40
Unknown12
Recruiting8
Not Yet Recruiting5
Active Not Recruiting3
Withdrawn2

Trial Success Rate

97.6%

Benchmark: 86.5%

Based on 40 completed trials

Clinical Trials (72)

Showing 20 of 20 trials
NCT07537426Not ApplicableRecruiting

The Efficacy of Intradermal Acupuncture for Ocular Surface Diseases After Intractable Facial Paralysis

NCT07502378Phase 4RecruitingPrimary

Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic Keratopathy Patients With Tear Deficiency

NCT07490535Phase 4Not Yet RecruitingPrimary

This is a Single Center, Open-label Prospective Study to Evaluate the Effect of Xiidra® (Lifitegrast Ophthalmic Solution 5.0%) on Tear Film Biomarkers in Dry Eye

NCT04354545Recruiting

Treatment of Ocular Discomfort in Glaucoma Patients Using Multiple Topical Medications

NCT07067294Not ApplicableCompleted

Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Cataract Surgery

NCT07298174Not Yet Recruiting

Wide Field OCTA in Ocular Diseases

NCT07297849Not ApplicableRecruiting

Eyelid Closure in Keratometry

NCT07230548Phase 3CompletedPrimary

Effect of Four Different Diagnostic Eye Drops on Tear Film Thickness

NCT07181668Not ApplicableCompleted

Effect of Low-Level Light Therapy on Ocular Surface Parameters in Patients Undergoing Femto-Lasik Surgery

NCT07168265Not ApplicableCompleted

The Effects of Androgen Replacement Therapy on Tear Osmolarity and Ocular Surface Parameters in Androgen Deficiency

NCT07000565Not ApplicableCompletedPrimary

The Effect of Eye Care With Artificial Tears and Normal Saline on Ocular Surface Disease in Mechanically Ventilated Pediatric Patients

NCT06375343Phase 1Not Yet Recruiting

Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive®

NCT06861985Not ApplicableCompletedPrimary

Effects of HFMH-EMS on Ocular Artery Circulation

NCT06370585Phase 1Completed

Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF

NCT05832996Phase 4Completed

Cool vs Room-temperature Artificial Tears

NCT06793514Phase 1Not Yet Recruiting

Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis

NCT04918823Phase 1CompletedPrimary

Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% in a PROSE Device

NCT06714799RecruitingPrimary

Analysis of Videodermatoscopic Parameters of Ocular, Periocular, Conjunctival and Palpebral Neoformations

NCT06624384Phase 1Not Yet Recruiting

Efficacy and Safety of Topical Cyclosporine 0.05% and Lifitgrast on the Ocular Surface Symptom After Photorefractive Keratectomy in Feiz Hospital, Isfahan, 2024

NCT06555367RecruitingPrimary

Clinical Application Research of Scleral Lenses in Ocular Surface Diseases

Scroll to load more

Research Network

Activity Timeline